Health Tech
-
Histotripsy: FDA Clears Non-Invasive Cancer Treatment, HOPE4LIVER Trial Shows Promising Results
Histotripsy, a non-invasive ultrasound therapy, is now FDA-approved for liver tumors. The HOPE4LIVER trial showed local control rates and safety profiles, but…
-
Smartwatches Overestimate Calories Burned, and Errors Grow With Body Fat, Florida Study Finds
COPENHAGEN, May 23 — The smartwatch on your wrist is probably lying to you about how many calories you just burned, and…
-
Delphi Diagnostics Offers Endocrine Activity Index Test for Stage II-III Breast Cancer
LONDON, July 17 — The genomic test that changed how oncologists decide whether to give chemotherapy for early breast cancer now has…
-
Global Oncology Precision Medicine Market Set for Robust Expansion Through 2031
GLOBAL — July 1, 2026 — The global market for oncology precision medicine is opening up fresh opportunities in diagnostics and therapeutics,…
-
Why Medical Deepfakes Are a Public Health Risk
WASHINGTON, June 25 — The rise of generative artificial intelligence has made it “really easy” to create convincing medical deepfakes, posing a…
-
ALS Patient Brad Smith Becomes Third Person to Receive a Neuralink Brain Implant
On 15 January 2024, Noland Arbaugh, a man living with tetraplegia, demonstrated that he could move a cursor and play an online…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Selangor International Care Expo 2026 Targets the Growing Care Economy
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
October FDA Approvals Beyond Cancer: Hives, Schizophrenia, Eye Disease, Hepatitis B and Crohn Disease
-
How New Immunotherapy Aims to Break the Cycle of Surgery for RRP Patients
-
BioSapien Begins First-in-Human MediChip Trial for Rectal Cancer at Burjeel
-
FDA Approves Tirzepatide to Reduce Heart Attack Risk in Type 2 Diabetes
-
UK Trial Aims to Cut Breast Cancer Radiotherapy from Three Weeks to Five Days
-
Nicole Eggert’s Cancer Bills and a Trial That Cut Financial Toxicity for Patients
-
Why Retirees Must Shift Emergency Fund Strategies Beyond Standard Three-Month Rules
-
Why Personal Bankruptcies Jumped 11% Despite Economic Growth
-
How Lendmark Financial Services Is Expanding Access to Credit in Local Markets
-
Four in 10 US Adults Carry Health Care Debt as Michigan Wipes Another $21 Million
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992